» Articles » PMID: 36939963

Integrative Medicine for Ovarian Cancer

Overview
Journal Curr Oncol Rep
Publisher Current Science
Specialty Oncology
Date 2023 Mar 20
PMID 36939963
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Integrative oncology (IO) services provide a wide range of complementary medicine therapies, many of which can augment the beneficial effects of conventional supportive and palliative care for patients with ovarian cancer. This study aims to assess the current state of integrative oncology research in ovarian cancer care.

Recent Findings: We review the clinical research both supporting the effectiveness of leading IO modalities in ovarian cancer care as well as addressing potential safety-related concerns. There is growing amount of clinical research supporting the use of IO and implementation of integrative gynecological oncology models of care within the conventional supportive cancer care setting. Additional research is still needed in order to create clinical guidelines for IO interventions for the treatment of female patients with ovarian cancer. These guidelines need to address both effectiveness and safety-related issues, providing oncology healthcare professionals with indications for which these patients can be referred to the IO treatment program.

Citing Articles

Anti-proliferative Activity of Leaf Extracts on PA1 Human Ovarian Cancer Cell Lines.

Shettar P, Hiremath M, Kumbar V Arch Razi Inst. 2024; 79(2):426-436.

PMID: 39463706 PMC: 11512179. DOI: 10.32592/ARI.2024.79.2.426.


Prognostic role of long non-coding RNA USP30-AS1 in ovarian cancer: insights into immune cell infiltration in the tumor microenvironment.

Xiong J, Chen J, Sun X, Zhao R, Gao K Aging (Albany NY). 2023; 15(23):13776-13798.

PMID: 38054797 PMC: 10756134. DOI: 10.18632/aging.205262.


Comparative diagnostic accuracy of the IOTA SRR and LR2 scoring systems for discriminating between malignant and Benign Adnexal masses by junior physicians in Chinese patients: a retrospective observational study.

Tian C, Wen S, Zhao C, Yan X, Du J BMC Womens Health. 2023; 23(1):585.

PMID: 37940895 PMC: 10633950. DOI: 10.1186/s12905-023-02719-z.